September 28, 2014 | Israel Chemicals (ICL) announced the pricing of its New York Stock Exchange IPO at $7 a share. According to reports, ICL will sell over 60 million ordinary shares which are currently owned by the company’s majority shareholder, Israel Corporation, in a second offering at a price of $7 a share. In addition, the underwriters for the IPO, which include Morgan Stanley, Barclays Capital, Goldman Sachs, Deutsche Bank and BMO Capital Markets, will be given a 30-day option to purchase an additional 6 million shares. Due to Israel Corporations majority shareholder position in the company, ICL will not receive financial proceeds from the sale. ICL is a multi-national manufacturer, producer, developer and marketer of fertilizers, metals and other special purpose chemical products that was founded in 1968.
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors

Ashdod Port Investing In Startups As Part Of Innovation Strategy

Facebook comments